durvalumab,tremelimumab
astrazeneca,pfizer
['#gi', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm']
dr of presents data from durva+tremi study showing that plasma high tmb patient did have the highest survival however overall the survival benefit was modest across the trial #gionc #crcsm #asco22 
#FosterCare alum, #GIonc, #pallonc, and #survonc doc @ParkviewHealth.Uniting support and cancer care #supponc #hpm #hapc  Tweets are own.